The Investor Relations website contains information about GlycoMimetics, Inc.'s business for stockholders, potential investors, and financial analysts.
GlycoMimetics is a late clinical-stage biotechnology company discovering and developing glycobiology-based therapies for cancers and inflammatory diseases.
GlycoMimetics, Inc. Common Stock is estimated to report earnings on 05/01/2024. The upcoming earnings date is derived from an algorithm based on a company's ...
Find the latest institutional holdings data for GlycoMimetics, Inc. Common Stock (GLYC) ... Common Stock (GLYC) ... Investor Relations · Contact · Careers ...
Mar 1, 2024 · GlycoMimetics (GLYC) has issued an announcement. GlycoMimetics, Inc. has prepared a slide presentation for upcoming investor meetings, ...
Missing: relations | Show results with:relations
Get the latest GlycoMimetics, Inc. (GLYC) stock news and headlines to help you in your trading and investing decisions.
Nov 23, 2021 · Seeking Alpha's transcripts team is responsible for the development of all of our transcript-related projects.
Missing: relations | Show results with:relations
People also ask
What is the price target for GlycoMimetics?
Where is GlycoMimetics located?
(US:GLYC) has 79 institutional owners and shareholders ... Investor Shares, Axa S.a., Goldman Sachs Group Inc ... relation to any financial matter you should ...